Evidence map›Paper›PMID 26568649›Full record

ArticlePublic health reviews2014

Can Substance Use Disorders be Managed Using the Chronic Care Model? Review and Recommendations from a NIDA Consensus Group.

A Thomas McLellan, Joanna L Starrels, Betty Tai, Adam J Gordon, Richard Brown, Udi Ghitza, Marc Gourevitch, Jack Stein, Marla Oros, Terry Horton and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Public health reviews, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 1 synthesis or guideline pooled it, 100 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 1 country.

A Thomas McLellanThe Treatment Research Institute, Philadelphia PA, USA.
Joanna L StarrelsAlbert Einstein College of Medicine and Monte ore Medical Center, Bronx, NY, USA.
Betty TaiNational Institute of Health, National Institute on Drug Abuse, Bethesda, MD, USA.
Adam J GordonUniversity of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Richard BrownUniversity of Wisconsin, School of Medicine and Public Health, Madison, WI, USA.
Udi GhitzaNational Institute of Health, National Institute on Drug Abuse, Bethesda, MD, USA.
Marc GourevitchNew York University School of Medicine, Department of Population Health, New York, NY, USA.
Jack SteinNational Institute of Health, National Institute on Drug Abuse, Bethesda, MD, USA.
Marla OrosThe Mosaic Group, Baltimore MD. USA.
Terry HortonChristiana Care Health System, Division of Addiction Medicine, Wilmington DE, USA.
Robert LindbladThe EMMES Corporation, Rockville, MD, USA.
Jennifer McNeelyNew York University School of Medicine, Department of Population Health, New York, NY, USA.
National Institute on Drug Abuse · USNew York University · USAlbert Einstein College of Medicine · USChristiana Care Health System · USEmmes (United States) · USTreatment Research Institute · USUniversity of Pittsburgh · USUniversity of Wisconsin–Madison · US

Funding

Intramural NIH HHS Z99 DA999999
6 · The paper itself

Abstract

Brain imaging and genetic studies over the past two decades suggest that substance use disorders are best considered chronic illnesses. The passing of the Affordable Care Act in the United States has set the occasion for integrating treatment of substance use disorders into mainstream healthcare; and for using the proactive, team-oriented Chronic Care Model (CCM). This paper systematically examines and compares whether and how well the CCM could be applied to the treatment of substance use disorders, using type 2 diabetes as a comparator. The chronic illness management approach is still new in the field of addiction and research is limited. However comparative findings suggest that most proactive, team treatment-oriented clinical management practices now used in diabetes management are applicable to the substance use disorders; capable of being implemented by primary care teams; and should offer comparable potential benefits in the treatment of substance use disorders. Such care should also improve the quality of care for many illnesses now negatively affected by unaddressed substance abuse.

Indexed as

chronic care modelchronic illnesselectronic health recordshealthcare reformSubstance use disorderstype 2 diabetes management

Identifiers

PMID26568649
PMCPMC4643942
OpenAlexW2211865707

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.